EUVIMEDEUVIMED entdecken
Crossref

Comprehensive analysis of m 6 A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma

Hexin Li, Chang Li iD, Yuxiang Zhang, Weixing Jiang, Fubo Zhang, Xiaokun Tang, Gaoyuan Sun, Siyuan Xu, Xin Dong, Jianzhong Shou, Yong Yang, Meng Chen

Molecular Carcinogenesis · 2024-04 · 63 (4) · 677-687

DOI: 10.1002/mc.23680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 16.02.2024. Verfasst von Hexin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biobank, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of M…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Nanopore Sequencing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, CAMS Innovation Fund for Medical Sciences (CIFMS), Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N 6 ‐methyladenosine (m 6 A) is the most prevalent epigenetic modification on eukaryotic messenger RNAs. Recent studies have focused on elucidating the key role of m 6 A modification patterns in tumor progression. However, the relationship between m 6 A and transcriptional regulation remains elusive. Nanopore technology enables the quantification of m 6 A levels at each genomic site. In this study, a pair of tumor tissues and adjacent normal tissues from clear cell renal cell carcinoma (ccRCC) surgical samples were collected for Nanopore direct RNA sequencing. We identified 9644 genes displaying anomalous m 6 A modifications, with 5343 genes upregulated and 4301 genes downregulated. Among these, 5224 genes were regarded as dysregulated genes, encompassing abnormal regulation of both m 6 A modification and RNA expression. Gene Set Enrichment Analysis revealed an enrichment of these genes in pathways related to renal system progress and fatty acid metabolic progress. Furthermore, the χ 2 test demonstrated a significant association between the levels of m 6 A in dysregulated genes and their transcriptional expression levels. Additionally, we identified four obesity‐associated genes (FTO, LEPR, ADIPOR2, and NPY5R) among the dysregulated genes. Further analyses using public databases revealed that these four genes were all related to the prognosis and diagnosis of ccRCC. This study introduced the novel approach of employing conjoint analysis of m 6 A modification and RNA expression based on Nanopore sequencing to explore potential disease‐related genes. Our work demonstrates the feasibility of the application of Nanopore sequencing technology in RNA epigenetic regulation research and identifies new potential therapeutic targets for ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsNanopore SequencingHumansTranscriptomeEpigenomeEpigenesis, GeneticRNAAlpha-Ketoglutarate-Dependent Dioxygenase FTO

Stichwörter der Autor:innen

N6-methyladenosineNanopore sequencingprognosisrenal carcinoma

Substanzen

RNAFTO protein, humanAlpha-Ketoglutarate-Dependent Dioxygenase FTO

Autor:innen und Institutionen

  • Clinical Biobank, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Cancer Data Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Oncology, Huai'an TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Jiangsu, China.

ORCID-Profile: Chang Li

Förderung

  • Beijing Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences (CIFMS)
  • Fundamental Research Funds for the Central Universities
  • Beijing Hope Run Special Fund of Cancer Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Li, H., Li, C., Zhang, Y., Jiang, W., Zhang, F., Tang, X., Sun, G., Xu, S., Dong, X., Shou, J., Yang, Y., & Chen, M. (2024). Comprehensive analysis of m 6 A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma. Molecular Carcinogenesis, 63(4), 677-687. https://doi.org/10.1002/mc.23680

Vancouver

Li H, Li C, Zhang Y, Jiang W, Zhang F, Tang X, et al. Comprehensive analysis of m 6 A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma. Molecular Carcinogenesis. 2024;63(4):677-687. doi:10.1002/mc.23680

BibTeX
@article{Li2024,
  author = {Li, Hexin and Li, Chang and Zhang, Yuxiang and Jiang, Weixing and Zhang, Fubo and Tang, Xiaokun and Sun, Gaoyuan and Xu, Siyuan and Dong, Xin and Shou, Jianzhong and Yang, Yong and Chen, Meng},
  title = {Comprehensive analysis of m 6 A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {4},
  pages = {677--687},
  doi = {10.1002/mc.23680}
}
Kostenlos starten →